Recent advances, approaches and challenges in targeting pathways for potential COVID-19 vaccines development
- PMID: 33006053
- PMCID: PMC7529090
- DOI: 10.1007/s12026-020-09154-4
Recent advances, approaches and challenges in targeting pathways for potential COVID-19 vaccines development
Abstract
During the COVID-19 pandemic in a modern era, there is a global consensus on the need for the rapid development of a vaccine against SARS-CoV-2 for effective and sustainable control. Developing these vaccines is fundamental to public health. This urgent need is supported by the scientific explosion in structural and genomic biology that facilitates the urgent development of an ideal COVID-19 vaccine, using new pathways to facilitate its large-scale development, testing, and manufacture. Here, we summarize the types of COVID-19 candidate vaccines, their current stage in early testing in human clinical trials, and the challenges for their implementation.
Keywords: COVID-19 pandemic; Candidate vaccines; Efficacy; Immunology; Public health; Quality; SARS-CoV-2; Safety.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures
References
-
- Docea AO, Tsatsakis A, Albulescu D, Cristea O, Zlatian O, Vinceti M, Moschos SA, Tsoukalas D, Goumenou M, Drakoulis N, Dumanov JM, Tutelyan VA, Onischenko GG, Aschner M, Spandidos DA, Calina D. A new threat from an old enemy: re-emergence of coronavirus. Int J Mol Med. 2020;45(6):1631–1643. - PMC - PubMed
-
- Goumenou M, Sarigiannis D, Tsatsakis A, Anesti O, Docea AO, Petrakis D, Tsoukalas D, Kostoff R, Rakitskii V, Spandidos DA, Aschner M, Calina D. COVID-19 in Northern Italy: an integrative overview of factors possibly influencing the sharp increase of the outbreak. Mol Med Rep. 2020;22(1):20–32. - PMC - PubMed
-
- Tsatsakis A, Petrakis D, Nikolouzakis TK, Docea AO, Calina D, Vinceti M, Goumenou M, Kostoff RN, Mamoulakis C, Aschner M, Hernández AF. COVID-19, an opportunity to reevaluate the correlation between long-term effects of anthropogenic pollutants on viral epidemic/pandemic events and prevalence. Food Chem Toxicol. 2020;141:111418. - PMC - PubMed
-
- Adams ER, Augustin Y, Byrne RL, et al. Rapid development of COVID-19 rapid diagnostics for low resource settings: accelerating delivery through transparency, responsiveness, and open collaboration. medRxiv; 2020. 10.1101/2020.04.29.20082099.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
